Keros has shaken up its leadership…
Keros has shaken up its leadership structure as the biotech [...]
Keros has shaken up its leadership structure as the biotech [...]
As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental [...]
With more than $1 billion in debt due in 2027, [...]
Werewolf Therapeutics is transforming its brand awareness and clinical trial [...]
The FDA approved Jazz’s Modeyso (dordaviprone), which was picked up [...]
The Trump administration has broken the law by withholding funds [...]
Alltrna, the preclinical Flagship Pioneering-backed biotech trying to turn transfer [...]
Contineum Therapeutics has pumped the brakes on two projects, freeing [...]
The Department of Health and Human Services has announced a [...]
President Donald Trump has doubled down on his plan to [...]